ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Novel Combination of Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit MLL-r AML
By
ASH 2022 Conference Coverage
FEATURING
Suresh Balasubramanian
By
ASH 2022 Conference Coverage
FEATURING
Suresh Balasubramanian
129 views
December 22, 2022
Login to view comments.
Click here to Login
Leukemia